Combination of HIV/malaria increases complications during pregnancy

October 24, 2002

Women with a combined HIV/malaria infection more frequently experience complications during pregnancy than healthy women. This is revealed in research from Kenya. However, to their surprise the researchers established that HIV-infected mothers with a mild malaria infection less frequently transmit the HIV infection to their children than HIV-infected mothers without malaria.

In Kenya, the epidemiologists Annemieke van Eijk and John Ayisi investigated the interaction between HIV and malaria as well as the effect of both infections on mother and child during and after the pregnancy. The research revealed that pregnant women have a greater chance of developing malaria. This chance is even greater if the woman is pregnant for the first time. Also women younger than 20 years and women with an HIV infection are more susceptible to malaria.

Women with the combination HIV/malaria turned out to have a greater chance of developing anaemia during pregnancy and after childbirth. Their children also developed anaemia more often. If the child has HIV, the chance of it developing anaemia is greater. If the child has both HIV and malaria, anaemia develops even more frequently.

Surprisingly it turned out that HIV-infected mothers with malaria transmitted the HIV infection to their children less frequently than mothers without malaria. However, in such cases the mother must have a mild malaria infection and not a severe form. Unfortunately it is still not possible to accurately predict whether a mild malaria infection will remain mild or develop into the severe form.

The researchers argue that many complications can be prevented in Kenya, as the majority of pregnant women attend at least one pregnancy check-up. During the check-up the midwife could take action, for example, by prescribing malaria medication or providing advice about special mosquito nets. If HIV is detected during the check-up, the physician or midwife can provide special medicines for this.
-end-
Further information can be obtained from Dr Annemieke van Eijk and Dr John Ayisi (Kenya Medical Research Institute, Centre of Disease Control), tel. 254-35-22-983 and 254-35-22-929, fax 254-35-22-981, e-mail avaneijk@kisian.mimcom.net and jayisi@kisian.mimcom.net. The doctoral thesis was defended on 15 October 2002. Dr Van Eijk's and Dr Ayisi's supervisor was Prof. P.A. Kager (University of Amsterdam and the Academic Medical Centre, University of Amsterdam).

On 16 October 2002 a symposium entitled 'Malaria and HIV infection in pregnancy' was held at the University of Amsterdam Medical Centre in response to the doctoral research of John Ayisi and Annemieke van Eijk. Further information about this symposium can be obtained from Eva Hartkamp (secretariat Infectious Diseases, Tropical medicine and Aids), tel. 31-205-664-380, e-mail e.l.hartkamp@amc.uva.nl. A copy of the thesis can also be obtained from Eva Hartkamp.

The research was funded by the Netherlands organisation for Scientific Research (NWO).

Netherlands Organization for Scientific Research

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.